Cochlear Implants Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: June 30, 2023 Report Code: GDME1556EPD-ST

Select Item

Cochlear Implants Pipeline Market Report Overview

A Cochlear Implant (CI) bionic ear is a device that can be surgically implanted into a person’s cochlea to stimulate it to enhance or restore hearing. It works by directly stimulating any functioning auditory nerve inside the cochlea with electrical impulses. One cochlear implant includes a microphone, speech processor, transmitter and receiver/stimulator, and electrode array.

The cochlear implants pipeline market research report provides comprehensive information about the cochlear implants pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Territories The US, Europe, Finland, France, Austria, Czech Republic, Denmark, Hungary, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, and the United Kingdom
Key Regulatory Paths PMA, CE, and 510 (k)
Leading Companies Advanced Bionics AG, Advanced Bionics LLC, Auritec Pharmaceuticals Inc, Ceragenix Pharmaceuticals, Inc. (Inactive), Cochlear Ltd, Demant A/S, Hannover Medical School, Huntington Medical Research Institutes, Labyrinth Devices, OtoKinetics Inc, and Sonova Holding AG
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Cochlear Implants Pipeline Market Segmentation by Territories

Some of the cochlear implant market territories are the US, Europe, Finland, France, Austria, Czech Republic, Denmark, Hungary, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, and the United Kingdom. As of June 2023, the United States has the highest number of pipeline products.

Cochlear Implants Pipeline Market Analysis, by Territories, 2023 (%)

Cochlear Implants Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the cochlear implants pipeline market, download a free report sample

Cochlear Implants Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the cochlear implants pipeline market are PMA, CE, and 510 (k) among others. As of June 2023, PMA was the most followed pathway for pipeline products.

Cochlear Implants Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Cochlear Implants Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the cochlear implants pipeline market, download a free report sample

Cochlear implants Pipeline Market – Competitive Landscape

Some of the key companies in the cochlear implants pipeline market are Advanced Bionics AG, Advanced Bionics LLC, Auritec Pharmaceuticals Inc, Ceragenix Pharmaceuticals, Inc. (Inactive), Cochlear Ltd, Demant A/S, Hannover Medical School, Huntington Medical Research Institutes, Labyrinth Devices, OtoKinetics Inc, and Sonova Holding AG among others.

Advanced Bionics AG: Advanced Bionics AG (Advanced Bionics) develops, manufactures, and markets cochlear implant systems and hearing care solutions. Advanced Bionics is headquartered in Stafa, Zurich, Switzerland.

Segments Covered in the Report

Cochlear Implants Pipeline Market Territories Outlook

  • The US
  • Europe
  • Finland
  • France
  • Austria
  • Others

Cochlear Implants Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • 510(k)

Scope

  • Extensive coverage of the cochlear implants under development

  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities

  • Reviews the major players involved in the development of cochlear implants and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with the potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of cochlear implants under development

  • Develop market-entry and market-expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Advanced Bionics AG
Advanced Bionics LLC
Auritec Pharmaceuticals Inc
Ceragenix Pharmaceuticals, Inc. (Inactive)
Cochlear Ltd
Demant A/S
Hannover Medical School
Huntington Medical Research Institutes
Labyrinth Devices
MED-EL Elektromedizinische Gerate Gesellschaft mbH
Naval Information Warfare Center Pacific
Northwestern University
OtoKinetics Inc
Sonova Holding AG
Tel Aviv Sourasky Medical Center
Trinity College Dublin
University of Michigan Pediatric Device Consortium
University of Utah
University of Wisconsin Madison

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Cochlear Implants Overview 8

3 Products under Development 9

3.1 Cochlear Implants – Pipeline Products by Stage of Development 9

3.2 Cochlear Implants – Pipeline Products by Territory 10

3.3 Cochlear Implants – Pipeline Products by Regulatory Path 11

3.4 Cochlear Implants – Pipeline Products by Estimated Approval Date 12

3.5 Cochlear Implants – Ongoing Clinical Trials 13

4 Cochlear Implants – Pipeline Products under Development by Companies 14

4.1 Cochlear Implants Companies – Pipeline Products by Stage of Development 14

4.2 Cochlear Implants – Pipeline Products by Stage of Development 15

5 Cochlear Implants Companies and Product Overview 16

5.1 Advanced Bionics AG Company Overview 16

5.1.1 Advanced Bionics AG Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Advanced Bionics LLC Company Overview 17

5.2.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Auritec Pharmaceuticals Inc Company Overview 18

5.3.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 19

5.4.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 Cochlear Ltd Company Overview 20

5.5.1 Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

5.6 Demant A/S Company Overview 25

5.6.1 Demant A/S Pipeline Products & Ongoing Clinical Trials Overview 25

5.7 Hannover Medical School Company Overview 28

5.7.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 28

5.8 Huntington Medical Research Institutes Company Overview 29

5.8.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 29

5.9 Labyrinth Devices Company Overview 30

5.9.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 30

5.10 MED-EL Elektromedizinische Gerate Gesellschaft mbH Company Overview 33

5.10.1 MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 Naval Information Warfare Center Pacific Company Overview 34

5.11.1 Naval Information Warfare Center Pacific Pipeline Products & Ongoing Clinical Trials Overview 34

5.12 Northwestern University Company Overview 35

5.12.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 OtoKinetics Inc Company Overview 36

5.13.1 OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.14 Sonova Holding AG Company Overview 37

5.14.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 37

5.15 Tel Aviv Sourasky Medical Center Company Overview 38

5.15.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 38

5.16 Trinity College Dublin Company Overview 39

5.16.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 39

5.17 University of Michigan Pediatric Device Consortium Company Overview 40

5.17.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 40

5.18 University of Utah Company Overview 41

5.18.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 41

5.19 University of Wisconsin Madison Company Overview 42

5.19.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 42

6 Cochlear Implants- Recent Developments 43

6.1 Mar 02, 2023: Katya Kruglova to join Sonova’s Management Board as GVP Human Resources & Communications 43

6.2 Dec 20, 2022: Advanced Bionics to pay over $12 million for alleged false claims for cochlear implant processors 43

6.3 Dec 20, 2022: Advanced Bionics to pay over $12 million for alleged false claims for cochlear implant processors 45

6.4 Dec 06, 2022: Use of hearing aids and cochlear implants associated with a decreased risk of developing dementia 47

6.5 Nov 14, 2022: Sonova Holding First half results 2022/23 47

6.6 Oct 11, 2022: SONOVA HOLDING AG Announces Investor & Analyst Day 2022 50

6.7 Oct 11, 2022: Sonova Investor & Analyst Day 2022 Leading innovation and further expanding our reach 51

7 Appendix 52

7.1 Methodology 52

7.2 About GlobalData 55

7.3 Contact Us 55

7.4 Disclaimer 55

Table

Cochlear Implants – Pipeline Products by Stage of Development 9

Cochlear Implants – Pipeline Products by Territory 10

Cochlear Implants – Pipeline Products by Regulatory Path 11

Cochlear Implants – Pipeline Products by Estimated Approval Date 12

Cochlear Implants – Ongoing Clinical Trials 13

Cochlear Implants Companies – Pipeline Products by Stage of Development 14

Cochlear Implants – Pipeline Products by Stage of Development 15

Advanced Bionics AG Pipeline Products & Ongoing Clinical Trials Overview 16

Naida CI Marvel Sound Processor – Product Status 16

Naida CI Marvel Sound Processor – Product Description 16

Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 17

Hires Fidelity 120 Pediatrics – Product Status 17

Hires Fidelity 120 Pediatrics – Product Description 17

Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Steroid Eluting Cochlear Implant – Product Status 18

Steroid Eluting Cochlear Implant – Product Description 18

Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 19

Cerashield Coated Cochlear Inner Ear Implant – Product Status 19

Cerashield Coated Cochlear Inner Ear Implant – Product Description 19

Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

Nucleus 7 Sound Processor For Nucleus 22 Implant – Product Status 20

Nucleus 7 Sound Processor For Nucleus 22 Implant – Product Description 20

Nucleus Kanso 2 Sound Processor – Product Status 21

Nucleus Kanso 2 Sound Processor – Product Description 21

Nucleus Profile Plus – Product Status 21

Nucleus Profile Plus – Product Description 22

Cochlear Ltd – Ongoing Clinical Trials Overview 23

Nucleus Kanso 2 Sound Processor – A Pre-market, Open-label, Within Subject Study, of Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients Compared With the CP1150 Sound Processor and Their Current Sound Processor. 24

Demant A/S Pipeline Products & Ongoing Clinical Trials Overview 25

Neuro 2 – Product Status 25

Neuro 2 – Product Description 25

Demant A/S – Ongoing Clinical Trials Overview 26

Neuro 2 – Pupillometry Techniques Usage to Quantify the Programming Parameters Effect in the Auditory Effort in Zti Opticon Cochlear Implant Adult Users 27

Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 28

Optical Cochlea Stimulator – Product Status 28

Optical Cochlea Stimulator – Product Description 28

Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 29

Multisite Device – Product Status 29

Multisite Device – Product Description 29

Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 30

MVI Vestibular Implant System – Product Status 30

MVI Vestibular Implant System – Product Description 30

Labyrinth Devices – Ongoing Clinical Trials Overview 31

MVI Vestibular Implant System – First-in-human Early Feasibility Study of Safety, Tolerability and Efficacy for a Multichannel Vestibular Implant in Individuals with Bilateral Severe-to-profound Loss of Vestibular Sensation 32

MVI Vestibular Implant System – Vestibular Implantation in Older Adults 32

MVI Vestibular Implant System – Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction 32

MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview 33

Totally Implantable Cochlear Implant (TICI) – Product Status 33

Totally Implantable Cochlear Implant (TICI) – Product Description 33

Naval Information Warfare Center Pacific Pipeline Products & Ongoing Clinical Trials Overview 34

Bionic Cochlea Implant – Product Status 34

Bionic Cochlea Implant – Product Description 34

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 35

Cochlear Implant – Product Status 35

Cochlear Implant – Product Description 35

OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Krescendo I – Product Status 36

Krescendo I – Product Description 36

Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 37

Next Generation Cochlear Implant – Product Status 37

Next Generation Cochlear Implant – Product Description 37

Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 38

Implant Electrode Extender – Product Status 38

Implant Electrode Extender – Product Description 38

Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 39

Closed-loop Cochlear Implant – Product Status 39

Closed-loop Cochlear Implant – Product Description 39

University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 40

Enhanced Cochlear Implant Device – Product Status 40

Enhanced Cochlear Implant Device – Product Description 40

University of Utah Pipeline Products & Ongoing Clinical Trials Overview 41

Microphone Cochlear Implant – Product Status 41

Microphone Cochlear Implant – Product Description 41

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 42

Cochlear Implant – Product Status 42

Cochlear Implant – Product Description 42

Glossary 54

Figures

Cochlear Implants – Pipeline Products by Stage of Development 9

Cochlear Implants – Pipeline Products by Territory 10

Cochlear Implants – Pipeline Products by Regulatory Path 11

Cochlear Implants – Pipeline Products by Estimated Approval Date 12

Cochlear Implants – Ongoing Clinical Trials 13

Frequently asked questions

Cochlear Implants Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Cochlear Implants Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cochlear Implants reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cochlear Implants Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Cochlear Implants Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more